SMARCAD1a Antibody specifically targets the SMARCAD1 protein, an ATP-dependent DNA helicase involved in resolving R-loops at replication forks , maintaining heterochromatin integrity , and suppressing tumorigenesis . In zebrafish, smarcad1a and smarcad1b are homologs of human SMARCAD1, with smarcad1a showing tumor suppressor activity in malignant peripheral nerve sheath tumors (MPNSTs) .
SMARCAD1 resolves R-loops at active replication forks to prevent DNA damage . Antibodies like #12458 enable detection of SMARCAD1 localization at replication sites .
Mutant SMARCAD1 cells accumulate R-loops and exhibit replication-associated mutagenesis, detectable via Western blotting and immunofluorescence .
In zebrafish, smarcad1a loss accelerates MPNST tumorigenesis in tp53-mutant backgrounds . Antibodies validate SMARCAD1 depletion in tumor models (e.g., reduced protein levels in MPNST cell lines) .
SMARCAD1 deficiency correlates with impaired DNA double-strand break repair, measurable via pH2AX staining .
SMARCAL1 (a related helicase) regulates PD-L1 expression and innate immune evasion . While distinct from SMARCAD1, shared methodologies (e.g., ChIP, WB) apply to both targets .
Tumorigenesis: smarcad1a mutants (sa1299, p403) in zebrafish show 2–3× faster MPNST growth than controls .
DNA Repair: SMARCAD1 knockdown in human MPNST cells delays pH2AX resolution post-irradiation, confirming its role in DNA repair .
Therapeutic Potential: SMARCAD1-mutant cells exhibit sensitivity to PARP inhibitors, suggesting clinical relevance .
STRING: 7955.ENSDARP00000085842
UniGene: Dr.3950